日本の研究者らがアミロイドベータタンパク質の新たな種を特定した。この発見は神経変性疾患の早期治療につながる可能性がある。
日本時事通信によると、日本の科学者らはアルツハイマー病を引き起こすとされるタンパク質のクラスターを特定した。
この発見はアミロイドベータタンパク質の新たな種に関するもので、研究者らによると神経変性疾患の早期治療に寄与する可能性がある。
発表は2026年7月21日に行われた。
AIによるレポート AIによって生成された画像 事実確認済み
Researchers at Yale School of Medicine say they have identified two proteins on the surface of neurons that help shuttle misfolded alpha-synuclein—a key protein implicated in Parkinson’s disease—into healthy cells, a finding that could point to new strategies aimed at slowing progression.
Researchers at the University of California, Riverside have proposed that amyloid beta disrupts tau protein function inside neurons, potentially triggering Alzheimer's disease. The findings challenge the focus on external plaques as the primary cause.
AIによるレポート
A major analysis of genetic data has linked 127 gene locations to Alzheimer’s disease, including 48 previously unidentified ones. Researchers also flagged several genes as promising drug targets and highlighted changes in immune and nerve cells.
A cognitive speed-training game that reduces dementia risk appears to boost the brain's clearance of a key protein in men but not women, according to new research presented this week.
AIによるレポート
A protein known as SORLA can reduce the toxic effects of tau tangles linked to Alzheimer’s disease. Researchers at Sanford Burnham Prebys showed that higher levels of the protein limited brain atrophy and preserved neuron connections in mice. The findings were published July 17 in Science Advances.